4559:TYO
Zeria Pharmaceutical Co Ltd
¥1,898.00
0.00%
(0.00) 1D
Oct 5, 9:49:01 AM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4559...
Open
¥1,901
High
¥1,903
Low
¥1,895
Mkt. cap
95.18B
Avg. vol.
167.72K
Volume
28.80K
Dividend
2.58%
Quarterly dividend
¥12
Ex-dividend date
Sep 29, 2026
P/E ratio
10.17
52-wk high
¥2,434
52-wk low
¥1,878
EPS
¥187
Shares outstanding
50.11M
No. of employees
2K
Open
¥1,901
High
¥1,903
Low
¥1,895
Mkt. cap
95.18B
Avg. vol.
167.72K
Volume
28.80K
Dividend
2.58%
Quarterly dividend
¥12
Ex-dividend date
Sep 29, 2026
P/E ratio
10.17
52-wk high
¥2,434
52-wk low
¥1,878
EPS
¥187
Shares outstanding
50.11M
No. of employees
2K
News stories
From web sources and news partners
Foreign Policy Journal
·
22 minutes ago
Supreme Court Cases Involving Apple (NASDAQ: AAPL), Exxon (NYSE: XOM), And Intel (NASDAQ: INTC) Could Reshape Investor Portfolios
Proactive financial news
·
1 hour ago
Nova Minerals to host investor webinar on Estelle and US antimony strategy
Yahoo! Finance Canada
·
6 minutes ago
CABA,HERZ,TRIN,RPC,FFIN,NXRT,GO,BLCO,CULP,VSNT,KWY,FRST,VIRC,ENTX,BLIN,GRNT,SSP,GAIA,NRGV,AFCG,APCX,THRY,KLTR,BETR | Stock Prices | Quote Comparison
USA Today
·
15 hours ago
Is a stock market correction coming? Most Americans think so
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees1.75K
FoundedDec 22, 1955
Headquarters-
SectorPharmaceutical industry
Websitezeria.co.jp